We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+5.96%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$991M
AUM Growth
+$260M
Cap. Flow
+$254M
Cap. Flow %
25.68%
Top 10 Hldgs %
35.1%
Holding
398
New
299
Increased
7
Reduced
3
Closed
88
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNZ
101
DELISTED
D and Z Media Acquisition Corp.
DNZ
$2.9M 0.29%
+300,000
New +$2.92M
VOSO
102
DELISTED
Virtuoso Acquisition Corp. Class A Common Stock
VOSO
$2.9M 0.29%
+300,000
New +$2.92M
HCCC
103
DELISTED
Healthcare Capital Corp. Class A common stock
HCCC
$2.9M 0.29%
+300,000
New +$2.92M
RDBX
104
DELISTED
Redbox Entertainment Inc. Class A Common Stock
RDBX
$2.9M 0.29%
+295,325
New +$2.98M
OSTR
105
DELISTED
Oyster Enterprises Acquisition Corp. Class A Common Stock
OSTR
$2.89M 0.29%
+300,000
New +$2.9M
VHAQ
106
DELISTED
Viveon Health Acquisition Corp.
VHAQ
$2.88M 0.29%
+293,629
New +$2.93M
CRXT
107
DELISTED
Clarus Therapeutics Holdings, Inc. Common Stock
CRXT
$2.88M 0.29%
+285,460
New +$2.88M
ESSC
108
DELISTED
East Stone Acquisition Corporation Ordinary Shares
ESSC
$2.81M 0.28%
+281,697
New +$2.83M
AGAC.U
109
DELISTED
African Gold Acquisition Corp Units
AGAC.U
$2.81M 0.28%
+284,206
New +$2.83M
VENAU
110
DELISTED
Venus Acquisition Corporation Units
VENAU
$2.72M 0.27%
+271,925
New +$2.78M
TBCPU
111
DELISTED
Thunder Bridge Capital Partners III Inc. Units
TBCPU
$2.57M 0.26%
+259,980
New +$2.66M
AKIC
112
DELISTED
Sports Ventures Acquisition Corp. Class A Ordinary Shares
AKIC
$2.55M 0.26%
+264,663
New +$2.61M
DHCAU
113
DELISTED
DHC Acquisition Corp. Unit
DHCAU
$2.5M 0.25%
+250,000
New +$2.49M
COVAU
114
DELISTED
COVA Acquisition Corp. Unit
COVAU
$2.49M 0.25%
+250,000
New +$2.57M
MBAC.U
115
DELISTED
M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant
MBAC.U
$2.48M 0.25%
+250,000
New +$2.49M
EQHA
116
DELISTED
EQ Health Acquisition Corp.
EQHA
$2.47M 0.25%
+254,900
New +$2.47M
CLRM
117
DELISTED
Clarim Acquisition Corp. Class A Common Stock
CLRM
$2.46M 0.25%
+249,999
New +$2.45M
KBR icon
118
KBR
KBR
$4.56B
$2.45M 0.25%
+63,827
New +$2.04M
FINM
119
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
$2.37M 0.24%
+246,651
New +$2.4M
CI icon
120
Cigna
CI
$78.4B
$2.29M 0.23%
+9,457
New +$2.11M
TCACU
121
DELISTED
Tuatara Capital Acquisition Corporation Unit
TCACU
$2.25M 0.23%
+224,799
New +$2.29M
OEPW
122
DELISTED
One Equity Partners Open Water I Corp. Class A Common Stock
OEPW
$2.25M 0.23%
+229,998
New +$2.24M
ZFOX
123
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
$2.17M 0.22%
+220,824
New +$2.24M
WARR.U
124
DELISTED
Warrior Technologies Acquisition Company Units,eachconsistingofoneshare ofClassAcommonstockandone-halfofone warrant
WARR.U
$2.1M 0.21%
+211,600
New +$2.11M
FTEV.U
125
DELISTED
FinTech Evolution Acquisition Group Units, each consisting of one Class A Ordinary Share, and one-third of one redeemable warrant
FTEV.U
$2.02M 0.2%
+205,000
New +$2.05M

Similar funds

Mangrove Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Mangrove Partners held 398 positions worth $991M, up 36% from $731M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Mangrove Partners deployed $254M of net new capital in Q1 2021, opening 299 new positions and adding to 7 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 113,349 shares worth $17.3M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 7.8% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Navios Maritime Containers L.P. Common Units, an estimated $12.7M trimmed.

  • Mangrove Partners's largest Q1 2021 buy was Alexion Pharmaceuticals: 113,349 shares worth $17.3M.
  • Mangrove Partners added most to Pershing Square Tontine Holdings, Ltd. in Q1 2021, an estimated $27.1M increase.
  • Mangrove Partners's biggest Q1 2021 reduction was Navios Maritime Containers L.P. Common Units, cutting an estimated $12.7M.
  • Mangrove Partners fully exited TG Therapeutics in Q1 2021, selling an estimated $17.7M.
  • Mangrove Partners's ten largest holdings make up 35% of its $991M portfolio in Q1 2021.
  • Mangrove Partners opened 299 new positions and closed 88 in Q1 2021.
  • Mangrove Partners's portfolio value rose 36% quarter-over-quarter to $991M.

Based on Mangrove Partners's 13F filing for Q1 2021, filed 17 May 2021.